Cargando…

MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2

Colorectal cancer (CRC) is a leading cause of cancer-related death around the world whose recurrence and metastasis rate is high. Due to the underlying unclear pathogenesis, it is hard so far to predict the tumorigenesis and prevent its recurrence. YAP/TAZ has been reported to be activated and funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xia, Wang, Ai-li, Liu, Yuan-yuan, Zhao, Chen-xi, Zhou, Xue, Liu, Hai-long, Lin, Mo-bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769676/ https://www.ncbi.nlm.nih.gov/pubmed/33414893 http://dx.doi.org/10.1155/2020/5316276

Ejemplares similares

Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer
por: Liu, Hong, et al.
Publicado: (2016)

miR-429 Inhibits Differentiation and Promotes Proliferation in Porcine Preadipocytes
por: Peng, Ying, et al.
Publicado: (2016)

miR-372 promotes breast cancer cell proliferation by directly targeting LATS2
por: Cheng, Xueyuan, et al.
Publicado: (2018)

miR-429 inhibits migration and invasion of breast cancer cells in vitro
por: YE, ZHI-BIN, et al.
Publicado: (2014)

MiRNA-429 suppresses the growth of gastric cancer cells in vitro
por: Liu, Di, et al.
Publicado: (2012)

Theranostic application of miR-429 in HER2+ breast cancer
por: Cava, Claudia, et al.
Publicado: (2020)

miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells
por: Zhang, Min, et al.
Publicado: (2016)

IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells
por: Kim, Eun Sook, et al.
Publicado: (2016)

circ-0007707/miR-429/PDGFD Pathway Regulates the Progression of Gastric Cancer by Modulating the Immune-Gene Signature
por: Yang, Yang, et al.
Publicado: (2022)

Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer
por: Zhu, Wangyu, et al.
Publicado: (2014)

miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2
por: Han, Li-Li, et al.
Publicado: (2018)

MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1
por: Deng, Yi, et al.
Publicado: (2017)

Modulation of miR-429 during osmotic stress in the silverside Odontesthes humensis
por: Pagano, Antônio D., et al.
Publicado: (2022)

hsa-miR-429 targets CBX8 to promote cell apoptosis in diffuse large B-cell lymphoma
por: Liang, Yan, et al.
Publicado: (2021)

The Clinical Significance of MiR-429 as a Predictive Biomarker in Colorectal Cancer Patients Receiving 5-Fluorouracil Treatment
por: Dong, Sheng-jian, et al.
Publicado: (2016)

MiR-429 Inhibits Oral Squamous Cell Carcinoma Growth by Targeting ZEB1
por: Lei, Wanke, et al.
Publicado: (2015)

MiR-93 enhances angiogenesis and metastasis by targeting LATS2
por: Fang, Ling, et al.
Publicado: (2012)

miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma
por: Sun, Yingnan, et al.
Publicado: (2014)

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
por: Li, Yao, et al.
Publicado: (2023)

KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
por: Chen, Hong, et al.
Publicado: (2016)

Linc00641 promotes the progression of gastric carcinoma by modulating the miR-429/Notch-1 axis
por: Hang, Qun, et al.
Publicado: (2021)

Correction to: miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma
por: Sun, Yingnan, et al.
Publicado: (2021)

miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
por: Dai, Wenzhu, et al.
Publicado: (2019)

HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies
por: Bartoszewska, Sylwia, et al.
Publicado: (2023)

miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1
por: Wang, Zhihui, et al.
Publicado: (2019)

LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway
por: Wu, Liping, et al.
Publicado: (2020)

MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5
por: Chen, Liangyu, et al.
Publicado: (2018)

Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B
por: Yang, Jiangeng, et al.
Publicado: (2017)

Knockdown of USF1 Inhibits the Vasculogenic Mimicry of Glioma Cells via Stimulating SNHG16/miR-212-3p and linc00667/miR-429 Axis
por: Wang, Di, et al.
Publicado: (2019)

FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
por: Hsu, Hsi-Hsien, et al.
Publicado: (2019)

A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
por: Guo, Chunmei, et al.
Publicado: (2020)

Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR-429
por: Gu, Yongjuan, et al.
Publicado: (2021)

Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical Cancer
por: Shukla, Vaibhav, et al.
Publicado: (2023)

miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53
por: Lee, Kyung-Jun, et al.
Publicado: (2023)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

LncRNA PCAT19 induced by SP1 and acted as oncogene in gastric cancer competitively binding to miR429 and upregulating DHX9
por: Xiao, Lei, et al.
Publicado: (2022)

miR-429 promotes the proliferation of non-small cell lung cancer cells via targeting DLC-1
por: Xiao, Peng, et al.
Publicado: (2021)

Correction to: A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
por: Guo, Chunmei, et al.
Publicado: (2021)

Retraction Notice to: Knockdown of USF1 Inhibits the Vasculogenic Mimicry of Glioma Cells via Stimulating SNHG16/miR-212-3p and linc00667/miR-429 Axis
por: Wang, Di, et al.
Publicado: (2022)

Identification of the tumor-suppressive role of circular RNA-FOXO3 in colorectal cancer via regulation of miR-543/LATS1 axis
por: Deng, Yun-Yao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_us9tj3g0cgm8j08euttdm190fh